-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Arch Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2023.
- Arch Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$4.63M, a 473% decline year-over-year.
- Arch Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.94M, a 548% decline from 2022.
- Arch Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $433K, a 217% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)